[1]
AVES Editorial Office 2019. The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H. pylori eradication therapy. Turkish Journal of Gastroenterology. 23, 6 (Jul. 2019), 805–806.